Clinical Trial Record

Return to Clinical Trials

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions


2013-07


2024-04


2024-04


17667

Study Overview

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.

This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology.

  • All Diagnosed Health Conditions
  • ADD/ADHD
  • Alopecia Areata
  • Ankylosing Spondylitis
  • Asthma
  • Atopic Dermatitis Eczema
  • Beta Thalassemia
  • Bipolar Disorder
  • Breast Cancer
  • Celiac Disease
  • Cervical Cancer
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Chronic Kidney Diseases
  • Chronic Obstructive Pulmonary Disease
  • Colon Cancer
  • Colorectal Cancer
  • Crohn's Disease
  • Cystic Fibrosis
  • Depression
  • Diabetes Mellitus
  • Duchenne Muscular Dystrophy
  • Endometriosis
  • Epilepsy
  • Facioscapulohumeral Muscular Dystrophy
  • G6PD Deficiency
  • General Anxiety Disorder
  • Hepatitis B
  • Hereditary Hemorrhagic Telangiectasia
  • HIV/AIDS
  • Human Papilloma Virus
  • Huntington's Disease
  • Idiopathic Thrombocytopenic Purpura
  • Insomnia
  • Kidney Cancer
  • Leukemia
  • Lung Cancer
  • Lupus Nephritis
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Multiple Sclerosis
  • Myositis
  • Myotonic Dystrophy
  • Ovarian Cancer
  • Pancreatic Cancer
  • Parkinson's Disease
  • Polycystic Kidney Diseases
  • Prostate Cancer
  • Psoriasis
  • Psoriatic Arthritis
  • Rosacea
  • Scleroderma
  • Sickle Cell Anemia
  • Sickle Cell Trait
  • Sjogren's Syndrome
  • Skin Cancer
  • Spinal Muscular Atrophy
  • Systemic Lupus Erythematosus
  • Thrombotic Thrombocytopenic Purpura
  • Trisomy 21
  • Ulcerative Colitis
    • SAN-BB-01

    Study Record Dates

    These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

    Study Registration Dates Results Reporting Dates Study Record Updates

    2013-08-23  

    N/A  

    2024-04-16  

    2013-08-26  

    N/A  

    2024-04-18  

    2013-08-29  

    N/A  

    2024-04  

    Study Plan

    This section provides details of the study plan, including how the study is designed and what the study is measuring.

    Design Details

    Primary Purpose:
    N/A


    Allocation:
    N/A


    Interventional Model:
    N/A


    Masking:
    N/A


    Arms and Interventions

    Participant Group/ArmIntervention/Treatment
    : Health Condition

    Collect blood and other optional biospecimens from participants with a diagnosed health condition

    : Healthy Control

    Collect blood and other optional biospecimens from participants that have not been diagnosed with a health condition

    Primary Outcome MeasuresMeasure DescriptionTime Frame
    Biospecimen & Clinical Data CollectionTo collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results10 years
    Secondary Outcome MeasuresMeasure DescriptionTime Frame

    Contacts and Locations

    This section provides the contact details for those conducting the study, and information on where this study is being conducted.

    Participation Criteria

    Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

    Ages Eligible for Study:
    ALL

    Sexes Eligible for Study:
    18 Years

    Accepts Healthy Volunteers:
    1

      Inclusion Criteria:

    • All adults 18-100 years old
    • Able to provide proof of diagnosis
    • Live in USA

    • Exclusion Criteria:

    • Younger than 18 years old
    • Receipt of blood products within 30 days of study blood collection
    • Receipt of investigational drug within 30 days of study blood collection

    Collaborators and Investigators

    This is where you will find people and organizations involved with this study.


      • PRINCIPAL_INVESTIGATOR: Houman Hemmati, MD, Sanguine Biosciences

      Publications

      The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

      General Publications

      No publications available